Stakeholders responsible for updating physicians about genomics. Table A2 Goals in partnering with POG. (DOCX 12 kb
Study specific measures: Awareness, knowledge, and attitudes. The table presents descriptions of the...
The number of genes selected from TCGA studies by type of genetic alterations and cancer type. (XLSX...
The PeopleSeq Consortium surveys (pre-disclosure, post-disclosure, and catch-up surveys). (PDF, 1.4â...
Studentsâ awareness about pharmacogenomicsâthe table represents p values calculated with chi-squ...
Nomenclatures of relevance to genomic medicine. Table S2. Terminology systems that uniquely identify...
Supplemental materials including the course approval process, course organization, additional lesson...
Tables S1 and S2 contain descriptive statistics stratified by personal genomic testing company. (DOC...
The complete set of all genes included in the metagenes for each of the putative driver genes listed...
Table S1. Overview of projects in the PeopleSeq Consortium included in this analysis. Table S2. Stud...
Supplementary Tables: Tables S1-S11. See Additional file 2 for detailed table legends. (XLSX 144 kb
Table S1. Comprehensive list of single nucleotide polymorphisms (herein called genetic variants) and...
Table S1. contains the list of the genes used in the study, as well as indicators for which pathway ...
SNPs included in commercial personal genomic testing panels for cancer risk assessment in July 2012....
Participant characteristics including age, marital status, education, and number of relatives with P...
Levels of studentsâ awareness about genetic tests and pharmacogenomicsâthe table represents p va...
Study specific measures: Awareness, knowledge, and attitudes. The table presents descriptions of the...
The number of genes selected from TCGA studies by type of genetic alterations and cancer type. (XLSX...
The PeopleSeq Consortium surveys (pre-disclosure, post-disclosure, and catch-up surveys). (PDF, 1.4â...
Studentsâ awareness about pharmacogenomicsâthe table represents p values calculated with chi-squ...
Nomenclatures of relevance to genomic medicine. Table S2. Terminology systems that uniquely identify...
Supplemental materials including the course approval process, course organization, additional lesson...
Tables S1 and S2 contain descriptive statistics stratified by personal genomic testing company. (DOC...
The complete set of all genes included in the metagenes for each of the putative driver genes listed...
Table S1. Overview of projects in the PeopleSeq Consortium included in this analysis. Table S2. Stud...
Supplementary Tables: Tables S1-S11. See Additional file 2 for detailed table legends. (XLSX 144 kb
Table S1. Comprehensive list of single nucleotide polymorphisms (herein called genetic variants) and...
Table S1. contains the list of the genes used in the study, as well as indicators for which pathway ...
SNPs included in commercial personal genomic testing panels for cancer risk assessment in July 2012....
Participant characteristics including age, marital status, education, and number of relatives with P...
Levels of studentsâ awareness about genetic tests and pharmacogenomicsâthe table represents p va...
Study specific measures: Awareness, knowledge, and attitudes. The table presents descriptions of the...
The number of genes selected from TCGA studies by type of genetic alterations and cancer type. (XLSX...
The PeopleSeq Consortium surveys (pre-disclosure, post-disclosure, and catch-up surveys). (PDF, 1.4â...
DOI
Add to ORKG